Abiopharma

News list

Director Sordello Steven J 🟡 adjusted position in 0 shares (1 derivative) of Compass, Inc. (COMP) Transaction Date: May 01, 2026 | Filing ID: 000096

Full text

News bot May 5, 2026, 8:52 p.m.
🔍 Sordello Steven J (Director)

Company: Compass, Inc. (COMP)

Report Date: 2026-05-01
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 2,773
- Total shares sold: 2,773
Detailed Transactions and Holdings:
- Acquired 2,773 shares of Class A Common Stock (Direct)
  Date: 2026-05-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 212,069.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 2,773 shares of Restricted Stock Unit (RSU) (Derivative)
  Date: 2026-05-01 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F2, F2
Footnotes:
- F1: Each RSU represents a contingent right to receive one (1) share of the Issuer's Class A Common Stock upon settlement.
- F2: The RSUs shall vest as to 25% of the total shares on each of August 1, 2025, November 1, 2025, February 1, 2026, and May 1, 2026; and if not fully vested, will vest in full on the date of the next annual meeting of the Company's stockholders.